"Based on actions taken by the president earlier this year, the United States has secured enough Pfizer and Moderna doses for 300 million Americans. Johnson & Johnson vaccine makes up less than 5% of the recorded shots in arms in the United States to date," Jeff Zients, White House COVID-19 Response Coordinator, said in a statement. "This announcement will not have a significant impact on our vaccination plan. The company said they are also reviewing these cases with European regulators and "we have made the decision to proactively delay the rollout of our vaccine in Europe." Overall Vaccinations Continuing Apace Out of an abundance of caution, the CDC and FDA have recommended a pause in the use of our vaccine."
cases out of more than 6.8 million doses administered.
The United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA) are reviewing data involving six reported U.S. Johnson & Johnson in a statement said, "We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine. "I would like to stress these events are extremely rare," Woodcock said, "but we take all reports of adverse events after vaccination very seriously." The Company Response "There have been six reports of a severe stroke-like illness due to low platelet count and more than six million doses of the Johnson and Johnson vaccine have been administered so far," Schuchat said. To put the numbers in context, the six reported events occurred among millions of people who received the Johnson and Johnson vaccine to date. Not all of the six women involved in the events had a pre-existing condition or risk factor, Schuchat said. In contrast, the headaches associated with these blood clots come 1 to 2 weeks later and were very severe. Headache is a common side effect of COVID-19 vaccination, Marks added, but it typically happens within a day or two. If health care providers see people with these symptoms along with a low platelet count or blood clots, they should ask about any recent vaccinations, Marks added. "The issue here with these types of blood clots is that if one administers the standard treatment we give for blood clots, one can cause tremendous harm or it can be fatal," said Peter Marks, MD, director of the FDA Center for Biologics Evaluation and Research. Importantly, treatment for traditional blod clots, such as the drug heparin, should not be used for these clots. All six cases arose within 6 to 13 days of receipt of the Johnson and Johnson vaccine.
Headache, leg pain, abdominal pain and shortness of breath were among the reported symptoms. "For people who recently got the vaccine, in the last couple of weeks, look for symptoms." "For people who got the vaccine more than one month ago, the risk is very low at this time," she added. "I know the information today will be very concerning to Americans who have already received the Johnson and Johnson vaccine," said Anne Schuchat, MD, principal deputy director at the CDC. Last week, European regulators said they found a possible link between the shots and a very rare type of blood clot that occurs together with low blood platelets, one that seems to occur more in younger people.Of the six reported cases linked to the Johnson and Johnson vaccine, all are in women between the ages of 18 and 48 years, one woman died and another ended up in critical condition. Until now concern about the unusual blood clots has centered on the vaccine from AstraZeneca, which has not yet received authorization in the U.S. The agencies recommend that people who were given the J&J vaccine should contact their doctor if they experience severe headache, abdominal pain, leg pain or shortness of breath within three weeks. The doctors are hoping to ensure people that they’re doing everything they can to make sure the shots are safe, and if there’s any doubt, they’ll take a step back. Our message is, in doing this, we feel we’re taking the route that will provide the most safety for the patients by enabling health care professionals to recognize, to properly treat and to properly report any events that might happen,” said Woodcock. We feel that is a very important tool to get this pandemic under control.
0 kommentar(er)
